Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria Triantafyllidou"'
Autor:
Valérie M. Schwitzgebel, Jean-Louis Blouin, Barbara Dehos, Bettina Köhler-Ballan, Jardena J. Puder, Claudine Rieubland, Maria Triantafyllidou, Anne Zanchi, Marc Abramowicz, Thierry Nouspikel
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMutations in the GCK gene cause Maturity Onset Diabetes of the Young (GCK-MODY) by impairing glucose-sensing in pancreatic beta cells. During pregnancy, managing this type of diabetes varies based on fetal genotype. Fetuses carrying a GCK m
Externí odkaz:
https://doaj.org/article/e4add68890ec4c8bb0e802631da0d9d9
Autor:
Asimina Fylaktou, Sotiria Dimou-Besikli, Eleni Gavriilaki, Militsa Bitzani, Maria Triantafyllidou, Polychronis Tasioudis, Afroditi K. Boutou, Anastasia Papadopoulou, Penelope-Georgia Papayanni, Achilles Anagnostopoulos, Anastasia Iatrou, Georgios Karavalakis, Dimitrios Chasiotis, Diamantis Chloros, Ioannis Kioumis, Kiriakos Koukoulias, Eleni Geka, Chrysavgi Giannaki, Aphrodite Georgakopoulou, Eleni Siotou, Evangelia Yannaki
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an urgent need for the development of effective therapies for coronavirus disease 2019 (COVID-19). Methods We first tested SARS-CoV-2–specific T-cell (CοV-2
Autor:
Janina Vavanikunnel, Lilian Sewing, Maria Triantafyllidou, Anna Steighardt, Sandra Baumann, Andrea Egger, Leticia Grize, Barbara Felix, Marius Kraenzlin, Christoph Henzen, Christian Meier
Determinants of low bone turnover in type 2 diabetes (T2DM) are poorly understood. To investigate the relationship between markers of bone turnover, glycaemic control, disease duration and calciotropic hormones in T2DM we assessed baseline biochemica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76335a01d80abf8b88ff7c69d179221b
Autor:
Maria Triantafyllidou
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 16
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum. 16
Wir berichten von einem zuvor gesunden Patienten, welcher 13 Tage nach Beginn einer oralen Mesalazin-Therapie, eine 5-ASA-induzierte Polyserositis mit Perimyokarditis und Begleitnephritis entwickelte.
Publikováno v:
BMJ Case Reports. :bcr-2017
We report the case of two patients with newly diagnosed primary hyperparathyroidism: a 40-year-old woman during pregnancy and a 60-year-old man with initial hypercalcaemic crisis. In the first case, a bilateral neck exploration with parathyroidectomy